Flörkemeier, I.; Hillmann, J.S.; Weimer, J.P.; Hildebrandt, J.; Hedemann, N.; Rogmans, C.; Dempfle, A.; Arnold, N.; Clement, B.; Bauerschlag, D.O.
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer. Int. J. Mol. Sci. 2022, 23, 10503.
https://doi.org/10.3390/ijms231810503
AMA Style
Flörkemeier I, Hillmann JS, Weimer JP, Hildebrandt J, Hedemann N, Rogmans C, Dempfle A, Arnold N, Clement B, Bauerschlag DO.
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer. International Journal of Molecular Sciences. 2022; 23(18):10503.
https://doi.org/10.3390/ijms231810503
Chicago/Turabian Style
Flörkemeier, Inken, Julia S. Hillmann, Jörg P. Weimer, Jonas Hildebrandt, Nina Hedemann, Christoph Rogmans, Astrid Dempfle, Norbert Arnold, Bernd Clement, and Dirk O. Bauerschlag.
2022. "Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer" International Journal of Molecular Sciences 23, no. 18: 10503.
https://doi.org/10.3390/ijms231810503
APA Style
Flörkemeier, I., Hillmann, J. S., Weimer, J. P., Hildebrandt, J., Hedemann, N., Rogmans, C., Dempfle, A., Arnold, N., Clement, B., & Bauerschlag, D. O.
(2022). Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer. International Journal of Molecular Sciences, 23(18), 10503.
https://doi.org/10.3390/ijms231810503